ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.85
-0.14%
US Tech 100
19,181.60
-0.43%
S&P 500
5,460.48
-0.41%
US Dollar vs CAD
1.36682
-0.05%
Bitcoin
63,289.83
0.99%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orphazyme AS (ORPH)

  7. Orphazyme AS (ORPH) News

ORPH

Orphazyme AS (ORPH)

Orphazyme AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORPH
DateTimeSourceHeadlineSymbolCompany
02/10/20236:07AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
06/09/20225:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
05/23/20223:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
05/16/20223:31PMEdgar (US Regulatory)Amended Notification That Form 20-f Will Be Submitted Late (nt 20-f/a)NASDAQ:ORPHOrphazyme AS
05/16/20223:27PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
05/16/20227:39AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/29/20226:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/29/20226:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/07/20225:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/06/20225:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/04/20224:10PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/01/20225:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/31/20224:42PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ORPHOrphazyme AS
03/31/20222:17PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/29/20226:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/24/20225:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ORPHOrphazyme AS
03/22/20227:02AMDow Jones NewsOrphazyme Begins Delisting ADSs From NasdaqNASDAQ:ORPHOrphazyme AS
03/22/20225:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/21/20223:24PMEdgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:ORPHOrphazyme AS
03/18/20227:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/10/20224:12PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/03/20226:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
02/24/20225:27AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
02/18/20223:13PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
02/14/20223:46PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
02/11/20226:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
02/03/20223:19PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
01/31/202211:45AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
01/25/20225:25AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
01/19/20225:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
 Showing the most relevant articles for your search:NASDAQ:ORPH

Your Recent History

TSXV
ROC.H
Red Oak Mining
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved